Pasithea Therapeutics Corp. Short Interest Down 90.7 percent in September Pasithea Therapeutics Corp. saw a large drop in short interest in the month of September. As of September 15th, there was short interest totalling 400 shares, a drop of 90.7 percent from the August 31st total of 4,300 shares. Approximately 0.1 percent of the shares of the stock are sold short. Based

Pasithea Therapeutics Corp. Short Interest Down 90.7 percent in September

KTTA Stock  USD 0.92  0.02  2.13%   
About 63% of Pasithea Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Pasithea Therapeutics Corp suggests that many traders are alarmed. The current market sentiment, together with Pasithea Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Pasithea Therapeutics stock news signals to limit their universe of possible portfolio assets.
Pasithea Therapeutics Corp. saw a large drop in short interest in the month of September. As of September 15th, there was short interest totalling 400 shares, a drop of 90.7 percent from the August 31st total of 4,300 shares. Approximately 0.1 percent of the shares of the stock are sold short. Based

Read at thelincolnianonline.com
news
  

Pasithea Therapeutics Fundamental Analysis

We analyze Pasithea Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pasithea Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pasithea Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Pasithea Therapeutics is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Pasithea Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pasithea Therapeutics stock to make a market-neutral strategy. Peer analysis of Pasithea Therapeutics could also be used in its relative valuation, which is a method of valuing Pasithea Therapeutics by comparing valuation metrics with similar companies.

Peers

Pasithea Therapeutics Related Equities

FBRXForte Biosciences   35.81   
0%
100.0%
ABVCABVC Biopharma   20.00   
0%
55.0%
QNRXQuoin Pharmaceuticals   10.79   
0%
30.0%
NTRBWNutriband Warrant   6.25   
0%
17.0%
RNXTRenovoRx   4.20   
0%
11.0%
KRONKronos Bio   2.99   
0%
8.0%
MNOVMediciNova   2.17   
0%
6.0%
VRAXVirax Biolabs   2.00   
0%
5.0%
KZRKezar Life   1.75   
4.0%
0%
KPRXKiora Pharmaceuticals   3.27   
9.0%
0%
REVBRevelation Biosciences   6.18   
17.0%
0%
INDPIndaptus Therapeutics   13.51   
37.0%
0%

Complementary Tools for Pasithea Stock analysis

When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities